Medica Reporting Limited - Cellular Pathology Services

CPV: Pathology services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Unspecified in notice

Recurring procurement

Unspecified in notice

First published

26 Mar 2026, 15:35 GMT

Last source update

14 Apr 2026, 10:41 BST

FTS notice number

2026/S 000-033614

Classification (CPV)

Pathology services

Delivery area

South West (UKK13)

Official registry OCID

ocds-h6vhtk-067580 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award. <br/><br/>The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 13th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. When the standstill period has closed and the contract has been awarded to the intended provider, the Authority will issue a Corrigendum to this notice declaring that the contract has now been awarded. <br/><br/>A Conflict of Interest (COI) assessment was conducted and key decision-makers and members of the bidding, and evaluation of teams, were required to disclose any potential conflicts. Upon review, no additional conflicts management measures were deemed necessary for this procurement process.

Publisher note: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 or Procurement Act 2023 do not apply to this award. <br/><br/>The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 13th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. When the standstill period has closed and the contract has been awarded to the intended provider, the Authority will issue a Corrigendum to this notice declaring that the contract has now been awarded. <br/><br/>A Conflict of Interest (COI) assessment was conducted and key decision-makers and members of the bidding, and evaluation of teams, were required to disclose any potential conflicts. Upon review, no additional conflicts management measures were deemed necessary for this procurement process.

• MEDICA REPORTING LIMITEDAwarded supplier05026045 One Priory Square, 6th Floor, Priory Street, Hastings, East Sussex, England, Hastings, UK, TN34 1EA

No document links were published on the notice.